Baird analyst Eric Coldwell maintains AmerisourceBergen (NYSE:ABC) with a Outperform and raises the price target from $199 to $201.
Cyclerion Shares Fall After Reprioritized Pipeline, Workforce Reduction
Cyclerion Therapeutics Inc (NASDAQ:CYCN) is reprioritizing development programs and focusing resources and capabilities on candidates for mitochondrial diseases. The company has…